Polycystic Ovary Syndrome Treatment Market will generate new growth opportunities 2022-2028 | Sanofi, Novartis AG
January 14, 2022
Polycystic Ovary Syndrome Treatment Market
Polycystic ovary syndrome can be explained as set of symptoms such as insulin sensitivity, menstrual regulatory
SEATTLE, WASHINGTON, UNITED STATES, January 14, 2022 /EINPresswire.com/ -- New Research Study "Polycystic Ovary Syndrome Treatment Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.
Polycystic ovary syndrome (PCOS) is a condition in which the ovaries produce an unusual amount of male sex hormones called androgens. A woman with polycystic ovaries may experience irregular menstrual cycles or a decreased ovulation frequency. Symptoms of PCOS can also include excess facial hair, acne, and male-pattern baldness. While PCOS is quite common, the prevalence of this disorder differs depending on the countries and definitions used. About one in three women may have polycystic ovaries. Some women with polycystic ovaries are healthy and ovulating normally. Some even experience no symptoms at all.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/1589
Growing initiatives taken by Private organizations and government to increase awareness about PCOS is expected to propel growth of the global polycystic ovary syndrome treatment market over the forecast period. Many of the countries are taking initiatives to spread awareness regarding PCOS and its treatment among women by supporting or conducting various programs. For instance, in August 2019, OZiva, a nutrition brand in India, launched its #MYPCOSStory campaign for the women suffering from the condition, and to spread awareness among women regarding the disease.
However, lack of approved drugs that directly target PCOS, and side effects of symptomatic treatment drugs are the factors expected to hamper growth of the global polycystic ovary syndrome treatment market during the forecast period.
Impact of COVID-19:
The outbreak of COVID-19 virus in Wuhan, China has adversely impacted the global polycystic ovary syndrome treatment market. Due to the global pandemic several nations implemented strict lockdown regulations, which resulted into disruption of various market activities including manufacturing, supply chain, product launches, and more. Many of the industries witnessed decline in the market growth during the pandemic including pharmaceuticals. However, relaxation in the lockdown regulations and introduction of new vaccines as well as declining number of COVID-19 cases are expected to support growth of the global polycystic ovary syndrome treatment market.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/1589
The global polycystic ovary syndrome treatment market is expected to expand, exhibiting a CAGR of 4.8% during the forecast period due to rise in the number of cases of polycystic ovary syndrome (PCOS). For instance, according to The National Center for Biotechnology Information (NCBI) U.S., India had 3.7% to 22.5% prevalence of polycystic ovary syndrome PCOS in 2019.
Among regions, Asia Pacific is expected to witness robust growth in the global polycystic ovary syndrome treatment market. This is attributed to increasing adoption of PCOS treatment products, development in R&D segment, improving healthcare infrastructure in the region.
Major players active in the global polycystic ovary syndrome treatment market are Teva Pharmaceutical Industries, Allergan plc, SANOFI, AstraZeneca plc, Pfizer Inc., Bayer AG., Novartis AG, Bristol-Myers Squibb Company, Mylan N.V, and Johnson and Johnson.
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗔𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝗨𝗦𝗗 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/1589
𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.